GS-9716

GS-9716 · Gilead Sciences

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GS-9716, covering 2026-01-07 to 2026-01-07. Get the full timeline:

Most recent: Clinical Trial Update: Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of GS-9716 as Monotherapy and in Combination With Anticancer Therapies in Adults With Solid Malignancies [Phase 1]

See pricing